Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Schellong

Showing results (21-30 of 139) with videos related to

Pageof 14
Sort By:
Monatsschrift Fur Kinderheilkunde|July 1, 1973
[Phototherapy of Rb-dependent erythroblastosis]G Roth-Maintz, G Schellong
Klinische Padiatrie|March 1, 1979
[Concordant leukemia in identical twins (author's transl)]J Brämswig, G Schellong, W Voss
Haematology and Blood Transfusion|January 1, 1990
Improved treatment results in the myelocytic subtypes FAB M1-M4 but not in FAB M5 after intensification of induction therapy: results of the German childhood AML studies BFM-78 and BFM-83J Ritter, U Creutzig, G Schellong
Leukemia|January 1, 1992
Treatment results of three consecutive German childhood AML trials: BFM-78, -83, and -87. AML-BFM-GroupJ Ritter, U Creutzig, G Schellong
European Journal of Pediatrics|May 1, 1992
Tubular function and histological findings in ifosfamide-induced renal Fanconi syndrome--a report of two casesR Rossi, U Helmchen, G Schellong
Gematologiia I Transfuziologiia|January 1, 1991
[Intensification of chemotherapy of acute myeloid leukemia in children: report on the studies of the AML-BFM 78 and AML-BFM 83 protocols]U Creutzig, I Ritter, G Schellong
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
Breast cancer following treatment of Hodgkin's disease--more reasons for less radiotherapy?J Wolf, G Schellong, V Diehl
Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|January 1, 1973
[Report on experiences in the treatment of childhood leukoses using irradiation of the CNS and combined cytostatic medication]H Gröbe, E Schnepper, G Schellong
Klinische Padiatrie|March 1, 1979
[Prognosis improvements in children with acute myelocytic leucemia after more intensive induction therapy (author's transl)]U Scheer, G Schellong, H Riehm
Blood|May 15, 1990
Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. AML-BFM Study GroupU Creutzig, J Ritter, G Schellong
Pageof 14

Showing results (21-30 of 139) with videos related to

Sort By:
Pageof 14
Monatsschrift Fur Kinderheilkunde|July 1, 1973
[Phototherapy of Rb-dependent erythroblastosis]G Roth-Maintz, G Schellong
Klinische Padiatrie|March 1, 1979
[Concordant leukemia in identical twins (author's transl)]J Brämswig, G Schellong, W Voss
Haematology and Blood Transfusion|January 1, 1990
Improved treatment results in the myelocytic subtypes FAB M1-M4 but not in FAB M5 after intensification of induction therapy: results of the German childhood AML studies BFM-78 and BFM-83J Ritter, U Creutzig, G Schellong
Leukemia|January 1, 1992
Treatment results of three consecutive German childhood AML trials: BFM-78, -83, and -87. AML-BFM-GroupJ Ritter, U Creutzig, G Schellong
European Journal of Pediatrics|May 1, 1992
Tubular function and histological findings in ifosfamide-induced renal Fanconi syndrome--a report of two casesR Rossi, U Helmchen, G Schellong
Gematologiia I Transfuziologiia|January 1, 1991
[Intensification of chemotherapy of acute myeloid leukemia in children: report on the studies of the AML-BFM 78 and AML-BFM 83 protocols]U Creutzig, I Ritter, G Schellong
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
Breast cancer following treatment of Hodgkin's disease--more reasons for less radiotherapy?J Wolf, G Schellong, V Diehl
Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|January 1, 1973
[Report on experiences in the treatment of childhood leukoses using irradiation of the CNS and combined cytostatic medication]H Gröbe, E Schnepper, G Schellong
Klinische Padiatrie|March 1, 1979
[Prognosis improvements in children with acute myelocytic leucemia after more intensive induction therapy (author's transl)]U Scheer, G Schellong, H Riehm
Blood|May 15, 1990
Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. AML-BFM Study GroupU Creutzig, J Ritter, G Schellong
Pageof 14